Eagle Strategies’s Abbott ABT Stock Holding History

Eagle Strategies’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-2,283	Closed	-$260K	–	209
2024 Q1	$260K	Buy	+2,283	New	+$262K	0.06%	228

Other funds holding ABT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Eagle Strategies's ABT Position: Q2 2024 in Review

Eagle Strategies sold out of Abbott (ABT) in Q2 2024, closing a stake of 2,283 shares — an estimated $260K sold.

Eagle Strategies first reported a position in ABT in Q1 2024 and held it in 1 quarter. The position peaked at $260K in Q1 2024. 2,862 funds tracked by Wall St. Rank hold ABT as of Q2 2024.

Eagle Strategies reported no remaining Abbott position as of Q2 2024 after selling out during the quarter.
Eagle Strategies sold 2,283 Abbott shares in Q2 2024, an estimated $260K.
Eagle Strategies first reported a position in Abbott in Q1 2024 and held it in 1 quarter.
Eagle Strategies's Abbott position peaked at $260K in Q1 2024.
2,862 funds tracked by Wall St. Rank held Abbott as of Q2 2024.

Based on Eagle Strategies's 13F filing for Q2 2024, filed 8 Aug 2024.